Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04266821 · ClinicalTrials.gov registry record · NA
Establishing Clinical Utility of a New Diagnostic Test for Patients Suffering From Pain: A CPV® Randomized Controlled Trial
A NA study, sponsored by Qure Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 154
- Enrollment target
NCT04266821 is a NA study that has completed, run by Qure Healthcare. The registered enrollment target is 154 participants.
The verdict
NCT04266821, a NA study, has completed, sponsored by Qure Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 154 participants
- Enrollment target
Study Summary
This study will collect high-quality data on how practicing primary care physicians across the U.S. currently manage patients experiencing chronic pain and how the results of Ethos Laboratories' test change clinical decision making. To do so, this study leverages simulated patient cases called Clinical Performance and Value vignettes (CPVs) in a proven methodology to rapidly measure physician care decisions.
Interventions
- OTHER Experimental Arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2020-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04266821
The ClinicalTrials.gov registry entry for NCT04266821 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Qure Healthcare, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Experimental Arm is the first listed.
NCT04266821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04266821 about?
NCT04266821 is a clinical study titled "Establishing Clinical Utility of a New Diagnostic Test for Patients Suffering From Pain: A CPV® Randomized Controlled Trial". This study will collect high-quality data on how practicing primary care physicians across the U.S. currently manage patients experiencing chronic pain and how the results of Ethos Laboratories' test change clinical decision making. To do so, this study leverages simulated patient cases called Clini...
What is the current status of trial NCT04266821?
This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2020-02-01. Estimated completion is 2020-05-31.
What interventions are being tested in trial NCT04266821?
The interventions under investigation include: Experimental Arm (OTHER).
Who is sponsoring clinical trial NCT04266821?
This trial is sponsored by Qure Healthcare, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.